Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk M W Verheul

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Nature Reviews. Cancer|May 25, 2007
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibitionHenk M W Verheul, Herbert M Pinedo
Expert Opinion on Emerging Drugs|June 7, 2005
Inhibition of angiogenesis in cancer patientsHenk M W Verheul, Herbert M Pinedo
Nederlands Tijdschrift Voor Geneeskunde|July 31, 2019
[Should older patients with cancer visit a geriatrician as well? The value of geriatric assessments]Kathelijn S Versteeg, Henk M W Verheul
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applicationsConnie R Jimenez, Henk M W Verheul
Angiogenesis|December 17, 2009
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?Kristy J Gotink, Henk M W Verheul
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Care for mental well-being of cancer patients: Support during and after primary treatment]Joost Dekker, Daan Brandenbarg, Henk M W Verheul
Journal of Kidney Cancer and VHL|March 23, 2017
The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell CancerKaamar Azijli, Kristy J Gotink, Henk M W Verheul
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 4, 2009
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibHenk J Broxterman, Kristy J Gotink, Henk M W Verheul
BMC Cancer|October 31, 2018
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancerJoeri A J Douma, Henk M W Verheul, Laurien M Buffart
Cancer Chemotherapy and Pharmacology|January 27, 2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugsHenk M W Verheul, David Z Qian, Michael A Carducci, et al.
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Nature Reviews. Cancer|May 25, 2007
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibitionHenk M W Verheul, Herbert M Pinedo
Expert Opinion on Emerging Drugs|June 7, 2005
Inhibition of angiogenesis in cancer patientsHenk M W Verheul, Herbert M Pinedo
Nederlands Tijdschrift Voor Geneeskunde|July 31, 2019
[Should older patients with cancer visit a geriatrician as well? The value of geriatric assessments]Kathelijn S Versteeg, Henk M W Verheul
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applicationsConnie R Jimenez, Henk M W Verheul
Angiogenesis|December 17, 2009
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?Kristy J Gotink, Henk M W Verheul
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Care for mental well-being of cancer patients: Support during and after primary treatment]Joost Dekker, Daan Brandenbarg, Henk M W Verheul
Journal of Kidney Cancer and VHL|March 23, 2017
The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell CancerKaamar Azijli, Kristy J Gotink, Henk M W Verheul
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 4, 2009
Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibHenk J Broxterman, Kristy J Gotink, Henk M W Verheul
BMC Cancer|October 31, 2018
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancerJoeri A J Douma, Henk M W Verheul, Laurien M Buffart
Cancer Chemotherapy and Pharmacology|January 27, 2007
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugsHenk M W Verheul, David Z Qian, Michael A Carducci, et al.
Pageof 23